Klp Kapitalforvaltning As Intra Cellular Therapies, Inc. Transaction History
Klp Kapitalforvaltning As
- $20.6 Billion
- Q4 2024
A detailed history of Klp Kapitalforvaltning As transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Klp Kapitalforvaltning As holds 20,500 shares of ITCI stock, worth $2.63 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,500Holding current value
$2.63 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ITCI
# of Institutions
391Shares Held
88.5MCall Options Held
220KPut Options Held
140K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.24 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$810 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$656 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$416 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$411 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.1B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...